These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 12616213

  • 1. Genetically engineered tumor cell vaccine in a head and neck cancer model.
    Couch M, Saunders JK, O'Malley BW, Pardoll D, Jaffee E.
    Laryngoscope; 2003 Mar; 113(3):552-6. PubMed ID: 12616213
    [Abstract] [Full Text] [Related]

  • 2. Spatial distribution of tumor vaccine improves efficacy.
    Couch M, Saunders JK, O'Malley BW, Pardoll D, Jaffee E.
    Laryngoscope; 2003 Aug; 113(8):1401-5. PubMed ID: 12897566
    [Abstract] [Full Text] [Related]

  • 3. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
    Tseng SH, Chen Y, Chang CJ, Tai KF, Lin SM, Hwang LH.
    Clin Cancer Res; 2005 Feb 15; 11(4):1639-49. PubMed ID: 15746069
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X, Wang Y, Dietrich MF, Andreeff M, Arlinghaus RB.
    Oncogene; 2006 Jul 27; 25(32):4483-90. PubMed ID: 16547503
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 Jul 27; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 6. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S, Bartholomew RM, Pezzoli P, Gutierrez A, Gouveia E, Bassett D, Soo Hoo W, Carlo DJ.
    Gene Ther; 2002 Oct 27; 9(19):1302-11. PubMed ID: 12224013
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
    Guo C, Liu QG, Yang W, Yao YM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb 27; 28(2):188-92. PubMed ID: 18250039
    [Abstract] [Full Text] [Related]

  • 9. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y.
    Cancer Gene Ther; 2000 Sep 27; 7(9):1279-85. PubMed ID: 11023201
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J, Wu JH, Bouganim N, Galipeau J.
    Cancer Res; 2004 Dec 15; 64(24):8795-9. PubMed ID: 15604233
    [Abstract] [Full Text] [Related]

  • 11. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 12. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model.
    Soo Hoo W, Lundeen KA, Kohrumel JR, Pham NL, Brostoff SW, Bartholomew RM, Carlo DJ.
    J Immunol; 1999 Jun 15; 162(12):7343-9. PubMed ID: 10358185
    [Abstract] [Full Text] [Related]

  • 13. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS, Weber S, Gan J, Rakhmilevich AL, Mahvi DM.
    Cancer Gene Ther; 1999 Mar 15; 6(1):81-8. PubMed ID: 10078967
    [Abstract] [Full Text] [Related]

  • 15. Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccine.
    Kayaga J, Souberbielle BE, Sheikh N, Morrow WJ, Scott-Taylor T, Vile R, Chong H, Dalgleish AG.
    Gene Ther; 1999 Aug 15; 6(8):1475-81. PubMed ID: 10467372
    [Abstract] [Full Text] [Related]

  • 16. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Yamaue H.
    Int J Oncol; 2007 Oct 15; 31(4):931-9. PubMed ID: 17786327
    [Abstract] [Full Text] [Related]

  • 17. Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy.
    Chen Y, Chang KJ, Hwang LH, Chen CN, Tseng SH.
    Int J Colorectal Dis; 2002 Nov 15; 17(6):388-95. PubMed ID: 12355214
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.
    Soiffer R, Hodi FS, Haluska F, Jung K, Gillessen S, Singer S, Tanabe K, Duda R, Mentzer S, Jaklitsch M, Bueno R, Clift S, Hardy S, Neuberg D, Mulligan R, Webb I, Mihm M, Dranoff G.
    J Clin Oncol; 2003 Sep 01; 21(17):3343-50. PubMed ID: 12947071
    [Abstract] [Full Text] [Related]

  • 19. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G, Hoffmann P, Pouwels M, Zlotta A, Schulman C, Velu T, Bruyns CA.
    J Immunother; 2009 Sep 01; 32(2):140-4. PubMed ID: 19238012
    [Abstract] [Full Text] [Related]

  • 20. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity.
    Nakamura M, Iwahashi M, Nakamori M, Ueda K, Matsuura I, Noguchi K, Yamaue H.
    Clin Cancer Res; 2002 Aug 01; 8(8):2742-9. PubMed ID: 12171908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.